219 related articles for article (PubMed ID: 18802921)
1. Human head and neck squamous cell carcinoma cells are both targets and effectors for the angiogenic cytokine, VEGF.
Tong M; Lloyd B; Pei P; Mallery SR
J Cell Biochem; 2008 Dec; 105(5):1202-10. PubMed ID: 18802921
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma.
Lalla RV; Boisoneau DS; Spiro JD; Kreutzer DL
Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):882-8. PubMed ID: 12925349
[TBL] [Abstract][Full Text] [Related]
3. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
[TBL] [Abstract][Full Text] [Related]
4. Signal transducers and activators of transcription 3 up-regulates vascular endothelial growth factor production and tumor angiogenesis in head and neck squamous cell carcinoma.
Masuda M; Ruan HY; Ito A; Nakashima T; Toh S; Wakasaki T; Yasumatsu R; Kutratomi Y; Komune S; Weinstein IB
Oral Oncol; 2007 Sep; 43(8):785-90. PubMed ID: 17169602
[TBL] [Abstract][Full Text] [Related]
5. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
Bran B; Bran G; Hörmann K; Riedel F
Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the steps of angiogenesis by human head and neck squamous cell carcinomas.
Benefield J; Petruzzelli GJ; Fowler S; Taitz A; Kalkanis J; Young MR
Invasion Metastasis; 1996; 16(6):291-301. PubMed ID: 9371228
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
[TBL] [Abstract][Full Text] [Related]
8. Modulation of endothelial cell network formation in vitro by molecular signaling of head and neck squamous cell carcinoma (HNSCC) exposed to cetuximab.
Jouan-Hureaux V; Boura C; Merlin JL; Faivre B
Microvasc Res; 2012 Mar; 83(2):131-7. PubMed ID: 21820450
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy.
Riedel F; Götte K; Hörmann K; Grandis JR
Adv Otorhinolaryngol; 2005; 62():103-20. PubMed ID: 15608422
[TBL] [Abstract][Full Text] [Related]
10. Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck.
Ninck S; Reisser C; Dyckhoff G; Helmke B; Bauer H; Herold-Mende C
Int J Cancer; 2003 Aug; 106(1):34-44. PubMed ID: 12794754
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.
Sauter ER; Nesbit M; Watson JC; Klein-Szanto A; Litwin S; Herlyn M
Clin Cancer Res; 1999 Apr; 5(4):775-82. PubMed ID: 10213212
[TBL] [Abstract][Full Text] [Related]
12. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance.
Salven P; Heikkilä P; Anttonen A; Kajanti M; Joensuu H
Mod Pathol; 1997 Nov; 10(11):1128-33. PubMed ID: 9388064
[TBL] [Abstract][Full Text] [Related]
14. Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion.
Hong X; Jiang F; Kalkanis SN; Zhang ZG; Zhang X; Zheng X; Mikkelsen T; Jiang H; Chopp M
J Exp Ther Oncol; 2007; 6(3):219-29. PubMed ID: 17552362
[TBL] [Abstract][Full Text] [Related]
15. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck.
Franchi A; Santucci M; Masini E; Sardi I; Paglierani M; Gallo O
Cancer; 2002 Nov; 95(9):1902-10. PubMed ID: 12404284
[TBL] [Abstract][Full Text] [Related]
17. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
[TBL] [Abstract][Full Text] [Related]
18. Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications.
Hasina R; Whipple ME; Martin LE; Kuo WP; Ohno-Machado L; Lingen MW
Lab Invest; 2008 Apr; 88(4):342-53. PubMed ID: 18283272
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
Neuchrist C; Erovic BM; Handisurya A; Fischer MB; Steiner GE; Hollemann D; Gedlicka C; Saaristo A; Burian M
Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
[TBL] [Abstract][Full Text] [Related]
20. Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck.
Do NY; Lim SC; Im TS
Oncol Rep; 2004 Aug; 12(2):229-37. PubMed ID: 15254682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
